Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of F13B mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of F13B mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of F13B protein | affects expression | 20106945
|
D001104 |
Arbutin |
Arbutin results in decreased expression of F13B mRNA | decreases expression | 17103032
|
D002994 |
Clofibrate |
PPARA protein affects the reaction [Clofibrate results in decreased expression of F13B mRNA] | affects reaction|decreases expression | 17585979
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of F13B mRNA | decreases expression | 20106945
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of F13B mRNA | increases expression | 16002434
|
D004958 |
Estradiol |
Estradiol results in decreased expression of F13B mRNA | decreases expression | 20106945
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of F13B mRNA | affects expression | 20451245
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of F13B mRNA | decreases expression | 15703262
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of F13B mRNA | increases expression | 16267337
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.08 | 11752688 15322242 14514962 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.13 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.61 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.96 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.17 | 16712894 17306315 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.11 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Clofibrate |
9.75 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.75 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.87 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
1.86 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.86 | 19861407 14630087 17289903 16675129 17261762 12948864 17018787 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.86 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.70 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
9.13 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
9.13 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
9.13 | 12907637 12619106 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
9.13 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
9.13 | 15276417 17306315 16507464 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
4.96 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.96 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 18670907 18850075 16120746 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.67 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Clofibrate |
17.03 | 1399818 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
17.03 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
17.03 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
17.03 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.04 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 15668235 12621046 8697196 16354765 15340226 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 20055451 10048152 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.23 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.56 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.38 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.38 | 11743745 11461765 11529661 17906064 14725611 10915739 16781746 19085960 12705907 16109766 11739529 16177239 12540782 17522070 10663392 19416960 18713872 11287661 14550746 18071297 2444490 11834606 10774834 19739265 19164858 15968718 19370779 12594235 17562736 19420014 15619225 14986274 16485898 16227642 19923254 11421492 12392966 12958197 16393943 16081117 12153990 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.38 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.36 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Clofibrate |
4.19 | 16707586 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.55 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.13 | 15138306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.09 | 18566989 11473722 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
MESH:D005177 |
Factor XIII Deficiency |
marker/mechanism |
|
| |
MESH:D005234 |
Fatty Liver |
|
Clofibrate |
8.54 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.54 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.21 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.21 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.94 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.92 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.46 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.41 | 11294989 10048152 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.66 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.11 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.30 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.30 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.02 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 16959395 16354765 18606429 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.84 | 16870215 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.14 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.14 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.10 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.93 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.07 | 16627594 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.71 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
15.19 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
15.19 | 10903974 8314463 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
15.19 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
15.19 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
13.22 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.22 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
13.22 | 15610895 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.30 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.30 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.66 | 12969438 11587558 19014921 16610002 19784758 12587719 19460945 16611625 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.40 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.76 | 9163691 18177683 2125692 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.76 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.76 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.15 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.15 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.28 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.50 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.50 | 17306315 15276417 17077188 19931552 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.50 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.66 | 11807958 16891317 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.75 | 19453300 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.05 | 19082730 16487513 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.78 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.05 | 16801185 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.41 | 16810080 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.09 | 18551238 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.57 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.88 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.97 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.71 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.44 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
10.14 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.14 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.25 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.01 | 18514411 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Clofibrate |
5.15 | 9802331 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.59 | 16049721 12819281 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.99 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.99 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.53 | 16870215 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.37 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.43 | 11399792 11222880 11896295 11118676 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.02 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.06 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.57 | 16289102 12479363 16644109 18247401 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.57 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.57 | 16039940 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.28 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.64 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.84 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.84 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.93 | 12854658 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.95 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.29 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.29 | 11723127 16712894 16452187 17306315 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.55 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.16 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.93 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.25 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.66 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.71 | 17120751 |